hypothes
flow
cytometri
potenti
rapid
detect
respiratori
viral
antigen
ii
techniqu
appli
viral
diagnosi
clinic
sampl
obect
studi
design
studi
identif
six
common
respiratori
viral
pathogen
flow
cytometri
viru
infect
uninfect
cultur
cell
model
posit
neg
clinic
sampl
ii
compar
flow
cytometri
establish
techniqu
viral
isol
immunofluoresc
microscopi
diagnosi
respiratori
syncyti
viru
infect
nasopharyng
aspir
taken
children
sent
virolog
laboratori
routin
virolog
diagnosi
result
viru
analys
popul
infect
noninfect
cell
clearli
discern
confirm
potenti
method
rapid
viral
diagnosi
clinic
sampl
ii
two
definit
employ
sampl
posit
flow
cytometri
compar
combin
establish
techniqu
sensit
specif
posit
neg
predict
valu
flow
cytometri
first
definit
second
definit
respect
conclus
test
studi
flow
cytometri
less
sensit
establish
techniqu
well
recent
develop
rapid
diagnost
techniqu
diagnosi
respiratori
syncyti
viru
infect
evalu
potenti
flow
cytometri
rapid
viral
diagnosi
warrant
acut
respiratori
tract
infect
among
common
caus
ill
infant
young
children
respiratori
syncyti
rs
viru
major
caus
sever
ill
requit
hospitalis
caus
bronchiol
case
commun
acquir
pneumonia
first
month
life
mclntosh
chanock
standard
procedur
diagnos
viral
respiratori
infect
particularli
infant
young
children
includ
examin
exfoli
epitheli
cell
respiratori
secret
immunofluoresc
microscopi
virusspecif
antibodi
viral
isol
tissu
cultur
tc
immunofluoresc
microscopi
rel
timeconsum
result
frequent
avail
follow
day
subject
rather
object
diagnosi
frequent
made
presenc
fluoresc
cell
requir
highli
train
oper
viral
isol
extrem
timeconsum
take
week
result
avail
inferior
diagnosi
respiratori
viral
infect
grover
et
al
avail
effect
therapi
rs
viru
infect
togeth
need
earli
prevent
measur
reduc
nosocomi
infect
prompt
develop
techniqu
rapid
diagnosi
rs
viru
infect
includ
sever
enzym
immunoassay
eia
detect
viral
antigen
clinic
sampl
halstead
et
al
subbarao
et
al
johnston
siegel
kok
et
al
freymuth
et
al
shell
vial
techniqu
compar
tc
method
sensit
specif
sever
recent
studi
polymeras
chain
reaction
also
increasingli
use
viral
diagnosi
clinic
sampl
encourag
result
expens
requir
elabor
precaut
avoid
contamin
lead
fals
posit
result
johnston
et
al
paton
et
al
new
method
rapid
diagnosi
rs
viru
infect
promis
requir
develop
use
recommend
routin
clinic
practic
flow
cytometri
techniqu
allow
rapid
object
assess
cellassoci
fluoresc
techniqu
therefor
potenti
provid
rapid
object
mean
identifi
respiratori
viral
infect
varieti
clinic
sampl
nasal
aspir
sputum
bronehoalveolar
lavag
exampl
use
vitro
viral
detect
pseudorabi
viru
porcin
leukocyt
wang
et
al
cytomegaloviru
cmv
cultur
lymphoblast
link
et
al
vivo
detect
herp
simplex
viru
type
cervic
epitheli
cell
aurelian
rubella
virus
human
leukocyt
oshea
et
al
cmv
bronchoalveolar
lavag
elmendorf
et
al
peripher
blood
mononuclear
cell
link
et
al
flowcytometr
assay
immunoreact
bead
use
detect
antibodi
human
immunodefici
viru
human
blood
prove
superior
enzym
immunoassay
scillian
et
al
leukocyt
popul
nasal
aspir
taken
rhinoviru
upper
respiratori
tract
infect
studi
use
flow
cytometri
levandowski
et
al
confirm
techniqu
capabl
identifi
cell
popul
nasal
aspir
sampl
studi
preliminari
studi
use
cell
cultur
alon
cell
cultur
inocul
rs
viru
influenza
type
parairdiuenza
viru
type
coronaviru
type
adenoviru
cmv
model
neg
posit
clinic
sampl
respect
carri
investig
potenti
techniqu
rapid
viral
diagnosi
carri
prospect
comparison
convent
virolog
techniqu
tc
flow
cytometri
diagnosi
rs
viru
infect
nasopharyng
aspir
npa
sampl
sent
routin
viral
diagnosi
period
follow
tissu
cultur
cell
line
viru
inocula
use
cell
rs
viru
adenoviru
mdck
cell
influenza
type
parainfluenza
viru
type
ceil
cmv
cell
coronaviru
infect
inocul
ceil
confirm
typic
cytopath
effect
cpe
parainfluenza
viru
type
immunofluoresc
microscopi
cultur
ceil
detail
monoclon
antibodi
mab
use
pilot
studi
follow
rs
viru
specif
f
protein
use
suppli
genet
system
corp
wa
coronaviru
specif
groupspecif
kd
peplomer
glycoprotein
use
dilut
suppli
chemicon
ca
influenza
type
specif
type
use
suppli
parainfluenza
viru
type
specif
parainfluenza
viru
type
use
suppli
adenoviru
specif
groupspecif
pentonbas
kda
protein
use
suppli
ci
uk
ltd
cmv
specif
cmv
earli
antigen
use
dilut
suppli
dakopatt
denmark
goat
anti
mousefitc
use
dilut
southern
biotechnolog
associ
inc
al
mab
infect
appropri
uninfect
ceil
process
analys
test
abil
flow
cytometri
differenti
infect
noninfect
ceil
ceil
harvest
gentl
scrape
singl
cultur
tube
approx
cell
spun
x
g
min
resuspend
ml
phosphatebuff
salin
pb
oxoid
ltd
basingstok
uk
incub
antiadenoviru
mab
fix
equal
volum
icecold
ethanol
min
remaind
left
unfix
preliminari
studi
demonstr
adenovirusinfect
ceil
stain
satisfactorili
fix
virusinfect
ceil
stain
equal
well
fix
unfix
cell
wash
twice
pb
spun
final
cell
pellet
incub
min
ixl
fitcconjug
mab
rs
viru
adenoviru
influenza
type
parainfluenza
viru
type
rain
lal
murin
mab
coronaviru
cmv
follow
wash
pb
incub
ktl
goat
anti
mousefitc
mab
label
cell
receiv
wash
pb
resuspend
ml
pb
analysi
flow
eytometri
perform
use
facscan
analys
bectondickinson
w
argon
ion
laser
excit
nm
green
fluoresc
wavelength
nm
measur
logadthrn
scale
cell
tube
count
histogram
construct
cell
number
versu
fluores
npa
sampl
sent
depart
virolog
southampton
gener
hospit
routin
viral
diagnosi
period
januari
april
includ
prospect
comparison
flow
cytometri
combin
result
tc
togeth
diagnosi
rs
viru
infect
receipt
sampl
divid
equal
portion
process
tc
flow
cytometri
first
aliquot
inocul
onto
cell
observ
develop
cpe
passag
sampl
demonstr
cpe
confirm
rs
virusinfect
immunofluoresc
microscopi
cytospin
prepar
tissu
cultur
cell
incub
fitc
conjug
antir
viru
mab
cocktail
two
mab
specif
rs
viru
n
f
protein
one
rnab
specif
rs
viru
f
protein
use
suppli
novobiochem
nottingham
uk
use
routin
rs
viru
diagnosi
second
aliquot
wash
min
ml
n
acetyl
cystein
room
temperatur
cytospun
onto
glass
slide
fix
aceton
airdri
stain
fitc
conjug
mab
rs
viru
use
ident
methodolog
examin
immunofluoresc
microscopi
sampl
flow
cytometri
process
cultur
cell
describ
mab
rs
viru
flow
cytometri
clinic
sampl
also
obtain
novobiochem
use
detail
permit
valid
comparison
method
made
flow
eytometri
perform
use
method
describ
cultur
cell
initi
studi
known
posit
neg
sampl
suggest
gate
could
set
histogram
less
cell
fell
within
gate
neg
sampl
cell
fell
within
gate
posit
sampl
gate
use
prospect
analysi
sampl
studi
comparison
flow
cytometri
combin
result
tc
also
made
use
definit
cell
within
gate
denot
posit
sampl
determin
whether
would
improv
sensit
without
loss
specif
sensit
specif
posit
neg
predict
valu
flow
cytometri
compar
tc
togeth
alon
calcul
definit
studi
approv
southampton
hospit
joint
ethic
subcommitte
clear
differenti
infect
uninfect
sampl
virus
studi
fig
parainfluenza
viru
type
infect
sampl
appear
two
distinct
cell
popul
half
ident
stain
intens
uninfect
sampl
half
increas
stain
suggest
half
cell
infect
sampl
infect
infect
sampl
howev
one
popul
cell
almost
entir
separ
uninfect
cell
suggest
major
cell
infect
gate
could
set
tabl
flu
influenza
type
infect
uninfect
mdck
cell
incub
influenza
mab
rsv
respiratori
syncyti
viru
infect
uninfect
hep
cell
incub
respiratori
syncyti
viru
mab
pf
parainfluenza
type
infect
uninfect
mdck
cell
incub
parainfluenza
type
mab
c
coronaviru
type
infect
uninfect
clone
cell
incub
coronaviru
mab
cmv
cytomegaloviru
infect
uninfect
cell
incub
cytomegaloviru
mab
ad
adenoviru
infect
uninfect
hep
cell
incub
adenoviru
mab
total
npa
sampl
process
flow
cytometri
studi
period
also
inocul
onto
cell
cultur
examin
sampl
unsuit
due
insuffici
cell
cytospin
prepar
sampl
rs
virusposit
tc
result
combin
total
method
togeth
flow
cytometri
definit
posit
result
cell
within
gate
yield
rs
virusposit
sampl
fig
compar
tc
combin
flow
cytometri
sensit
specif
posit
neg
predict
valu
tabl
definit
posit
result
cell
within
gate
flow
cytometri
yield
rs
virusposit
sampl
compar
tc
combin
flow
cytometri
sensit
specif
posit
neg
predict
valu
tabl
studi
demonstr
flow
cytometri
use
diagnosi
rs
viru
infect
clinic
sampl
although
less
sensit
current
method
widespread
clinic
use
flow
cytometri
specif
sampl
take
rain
process
depend
whether
stain
direct
indirect
larg
number
analys
rapidli
howev
consider
develop
would
requir
flow
cytometri
could
consid
place
rapid
viral
diagnosi
flow
cytometri
certain
theoret
advantag
current
method
addit
speed
process
assess
number
cell
express
given
degre
fluores
analys
object
accord
consist
predetermin
criteria
perform
larger
number
cell
routin
test
studi
minimum
number
cell
within
posit
gate
cell
cutoff
ceil
cutoff
maximum
cell
flow
cytometri
could
use
altern
immunofluoresc
microscopi
cytospin
tissu
cultur
cell
confirm
viru
isol
cell
cultur
studi
directli
compar
flow
cytornetri
immunofluoresc
cultur
cell
pilot
studi
carri
cultur
cell
demonstr
tabl
comparison
flow
cytometri
tissu
cultur
immunofluoresc
microscopi
immunofluoresc
microscopi
alon
use
cell
within
gate
definit
posit
sampl
flow
cytometri
dear
differenti
posit
neg
sampl
rs
viru
influenza
type
adenoviru
parainfluenza
viru
type
cmv
coronaviru
slightli
less
clearcut
broad
rang
intens
fluoresc
rel
high
fluoresc
neg
sampl
fig
tabl
flow
cytometri
could
also
use
altern
test
rapid
diagnosi
clinic
sampl
directli
benefit
rapid
object
diagnosi
attract
compar
alon
use
cut
specif
flow
cytometri
sensit
use
cut
sensit
cost
reduc
specif
clinic
sampl
demonstr
quit
variabl
degre
nonspecif
fluoresc
lower
gate
set
would
result
larg
number
fals
posit
result
attempt
made
block
fluoresc
bovin
serum
albumin
newborn
goat
serum
foetal
calf
serum
cow
milk
protein
without
success
data
shown
applic
clearli
requir
consider
develop
possibl
method
improv
result
includ
use
combin
flow
cytometri
nucleic
acid
hybridis
recent
report
tabl
comparison
flow
cytometri
tissu
cultur
immunofluoresc
microscopi
immulaofluoresc
microscopi
alon
use
cell
within
gate
definit
posit
sampl
flow
cytometri
diagnosi
cmv
infect
link
et
al
employ
doubl
stain
mab
cytokeratin
desmosom
protein
identifi
epitheli
cell
could
gate
virusspecif
fluores
assess
studi
qualiti
test
depend
qualiti
mab
mab
use
studi
commerci
avail
characteris
author
possibl
mab
use
identif
cmv
coronaviru
less
specif
bind
mab
cmv
coronaviru
also
notori
difficult
diagnos
use
addit
coronaviru
extrem
diflficult
cultur
mcintosh
et
al
cmv
may
take
week
grow
difficulti
interpret
studi
abil
exist
test
method
use
gold
standard
accur
identifi
neg
sampl
reduc
number
cell
requir
within
gate
move
posit
gate
lower
fluoresc
level
would
result
larger
number
fals
posit
flow
cytometri
howev
possibl
sampl
fact
fals
neg
exist
method
recent
demonstr
use
polymeras
chain
reaction
pcr
diagnosi
picornaviru
infect
high
fals
neg
rate
cell
cultur
method
picornavirus
pcr
detect
time
mani
posit
sampl
clinic
specimen
johnston
et
al
howev
recent
report
use
pcr
diagnosi
rs
viru
infect
clinic
sampl
show
pcr
equival
cell
cultur
paton
et
al
suggest
rs
viru
fals
neg
rate
cell
cultur
may
low
shape
histogram
fig
suggest
larg
popul
uninfect
cell
small
number
infect
cell
within
gate
also
suggest
unlik
larg
number
fals
neg
sampl
sever
recent
studi
report
good
specif
sensit
eia
comparison
cultur
rapid
diagnosi
rs
viru
infect
clinic
specimen
halstead
et
al
subbarao
et
al
johnston
siegel
kok
et
al
freymuth
et
al
although
flow
cytometri
use
studi
sensit
sever
report
eia
techniqu
develpo
flow
cytometri
outlin
could
consider
improv
perform
flow
cytometri
may
also
role
diagnosi
infect
clinic
sampl
bronchoalveolar
lavag
may
valu
diagnosi
rs
viru
infect
derish
et
al
investig
pathogenesi
viral
infect
particular
determin
cell
type
infect
sampl
taken
subject
activ
viral
infect
studi
requir
examin
potenti
flow
cytometri
diagnosi
viral
infect
virus
rs
viru
improv
upon
method
employ
studi
carri
comparison
possibl
method
rapid
viral
diagnosi
